Inhibition of Na<sup>+</sup>/H<sup>+</sup> exchanger isoform 3 improves gut fluidity and alkalinity in cystic fibrosis transmembrane conductance regulator‐deficient and F508del mutant mice

Qinghai Tan(Tongji Hospital), Ursula Seidler(Medizinische Hochschule Hannover), Xiu Renjie(Medizinische Hochschule Hannover), Steven R. Talbot(Medizinische Hochschule Hannover), Xinjie Tan(Nankai University), Dorothee Römermann(Medizinische Hochschule Hannover), Gabriella Di Stefano(Medizinische Hochschule Hannover)
British Journal of Pharmacology
November 12, 2020
10.1111/bph.15323
Cited by 27

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
|PLoS ONE|2007|478
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
|The Lancet|2017|449
Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II
|Science|1996|409